Hematological malignancy
Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy.
... with hematological malignancies (diagnosed 1992–2006) and their 235,868 matched controls to define the incidence and risk factors for suicide and suicide ...with hematological malignancies compared to ...
8
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
... comprised hematological malignancy subtypes, age, gender, concurrent hepatitis C infection, liver cirrhosis, hepatocellular carcinoma, dia- betes mellitus, allogeneic transplantation recipient, and ...
8
<em>SDF1-</em>3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
... of hematological malignancy in Caucasians, and the data cannot be calculated in Africans and Asians due to only one available study (Figure ...of hematological malignancy, the results showed ...
9
Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study
... with hematological malignancy who are admitted to the intensive care unit (ICU) due to complications of the under- lying malignant disease often have a prolonged stay in the ICU [1] and are believed to have ...
9
Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
... transplants, hematological disease (including severe aplastic anemia, pure red cell aplasia, and hematological malignancy), and sinusitis diagnosed during their hospital stay were enrolled in this ...
9
Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy
... anti-hematological malignancy agent when combined with other antitumor ...anti-hematological malignancy ability for both oncolytic virotherapy and ...
8
Original Article Incidence and risk factors of port related infections in patients with hematological malignancy
... only hematological cancer, the incidence was ...with hematological malignan- cy as it has been shown in many previous stud- ies that hematological malignancy itself is a much more highly ...
8
<p>Cardiovascular Diseases And Psychiatric Disorders During The Diagnostic Workup Of Suspected Hematological Malignancy</p>
... tological malignancy and lead to a diagnostic ...with hematological malignancy and biopsied individuals had greater access to healthcare providers and therefore higher risk of being recorded with ...
10
Recent thymic output function in patients with hematological malignancy
... with hematological malignancy, but the individual differences in thymic output of naı¨ve T cells were ...hematopoietic malignancy and relatively low sjTRECs ...in hematological childhood ...
10
The role of BCL11B in hematological malignancy
... The findings indicated that BCL11B haplo-insufficiency occurred across each of the major T-ALL molecular subtypes, including the early T-cell precursor, HOXA- positive, LEF1-inactivated, and TAL1-positive subtypes [19]. ...
6
Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects
... to hematological disease where it has been noted as one of five mixed-lineage leukemia associated genes whose up- regulation accompanies amplification of the MLL gene region of 11q23 ...
12
Changing face of Candida colonization pattern in pediatric patients with hematological malignancy during repeated hospitalizations, results of a prospective observational study (2016–2017) in shiraz, Iran
... with hematological malignancies [1, ...in hematological ma- lignancies could affect final clinical outcome, especially when colonization occurs with a strain that has reduced susceptibility to azole ...
9
Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (Grrr-OH) study
... Among the four diagnostic categories, the first group included patients with pneumonia as defined by a clini- cally or microbiologically documented low respiratory tract infection. Clinically documented infection ...
9
Platelet transfusions in patients with a hematological malignancy : improving the chain
... Hematological patients need more platelet transfusions when older products are transfused as the interval between transfusions is shortened and the risk of bleeding may increase with [r] ...
190
Angiogenesis in hematological malignancy – Evaluated by dynamic contrast-enhanced MRI
... Bone marrow angiogenesis can be measured by DCE-MRI. DCE-MRI is an imaging technique that appears to provide quantitative and biologically relevant information related to tumor vasculature and angio- genesis, which can ...
7
Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy
... and hematological cancer cell lines (Broad-Novartis Cancer Cell Line Encyclopedia [n = 338; left panel] and Oncomine database corresponds to GSE20306 data [n = 449] derived from ...
12
Factors influencing theengraftment of haematopoietic stem cell transplantion in patients with hematological malignancy
... In our study there was a definite correlation between CD34+ cell dose and speed of engraftment. Autologous PBSCT showed faster PBSC graft engraftment than allogenic PBSCT. The expected speed of engraftment could be ...
174
An unusual case of malignancy-related hypercalcemia
... to the second course of chemotherapy, wherein the patient required weekly dosing of intravenous bisphosphonates and large amounts of IV fluids to maintain calcium levels at a reasonable albeit elevated level. A positive ...
7
Malignant Melanocytic Matricoma and Criteria for Malignancy
... In conclusion, MMM is a very rare tumor but with characteristic cytological and architectural features. Recurrence and metastasis are two definite criteria for malignancy. Multinodular infiltrative growth, tumor ...
7
The role of A20 in the pathogenesis of lymphocytic malignancy
... This protein was originally identified as a key regulator of inflammation signaling pathways and a negative regu- lator of the nuclear factor kappa B (NF- κ B) activation pathway, which [r] ...
7